Pharma Journalist - Page 95 of 946 -

Fulcrum and Slate Medicines Agree to $245 Million Merger

LEO Pharma Acquires Dersimelagon Rights for Rare Skin Diseases

Sandoz and Henlius Expand Global Biosimilar Collaboration

Opus Genetics’ OPGx-LCA5 Gene Therapy Earns FDA RMAT Designation

BioVaxys and Sona Nanotech Enter Research Collaboration

Speaker Interview with Anna Karmann, Chief Medical Officer, AdvanCell

FDA Grants Fast Track for Alterity’s ATH434 in Multiple System Atrophy Treatment

Oral Semaglutide 25 mg Filing Accepted by FDA; Could Be First Oral GLP-1 for Obesity

TAE Life Sciences and Ohio State Partner on Boron Drug Innovation for Cancer Therapy

Teva and Alvotech Gain FDA Interchangeability for SELARSDI Biosimilar to Stelara

VERAXA and OmniAb Partner to Develop Novel Bispecific Antibody-Drug Conjugate

Illumina & Ovation.io Launch Novel GLP-1 Dataset for Faster Therapy Development

FDA Approves Johnson & Johnson’s IMAAVY for Broad Generalized Myasthenia Gravis Population